- There were around 10,700 new cases of bladder cancer in the UK in 2012, that’s around 29 people every day.
- Bladder cancer is the seventh most common cancer in the UK (2012).
- Bladder cancer accounts for 3% of all new cases in the UK (2012).
- In men, bladder cancer is the fourth most common cancer in the UK, with around 7,700 cases diagnosed in 2012.
- In women, bladder cancer is the 13th most common cancer in the UK, with around 3,000 cases diagnosed in 2012.
- More than half (54%) of cases of bladder cancer are diagnosed in people aged 75 and over.
- Since the late-1970s, bladder cancer incidence rates have decreased by around a fifth (21%) in Great Britain.
- Over the last decade, bladder cancer incidence rates have decreased by more than a tenth (12%) in the UK.
- Most bladder cancer cases are diagnosed at an early stage.
- In Europe, more than 151,000 new cases of bladder cancer were estimated to have been diagnosed in 2012. The UK incidence rate is the lowest in Europe for males and the 13th lowest for females.
- Worldwide, an estimated 429,000 new cases of bladder cancer were diagnosed in 2012, with incidence rates varying across the world.
- 1 in 39 men and 1 in 110 women will be diagnosed with bladder cancer during their lifetime.
Bladder cancer statistics
New cases of bladder cancer, 2012, UK
Deaths from bladder cancer, 2012, UK
Survive bladder cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of bladder cancer, UK
- Bladder cancer is the seventh most common cause of cancer death in the UK.
- Around 5,200 people died from bladder cancer in 2012 in the UK, that's 14 people every day.
- More than two thirds of bladder cancer deaths are in people aged 75 and over.
- Since the early 1990s, bladder cancer death rates in the UK have decreased by more than a third for men and by around a quarter for women.
- In Europe, around 52,400 people were estimated to have died from bladder cancer in 2012. The UK mortality rate is 10th lowest in Europe for males and eighth highest for females.
- Worldwide around 165,100 people were estimated to have died from bladder cancer in 2012, with mortality rates varying across the world.
- Half (50%) of people diagnosed with bladder cancer in England and Wales survive their disease for ten years or more (2010-11).
- More than half (53%) of people diagnosed with bladder cancer in England and Wales survive their disease for five years or more (2010-11).
- More than 7 in 10 (72%) people diagnosed with bladder cancer in England and Wales survive their disease for one year or more (2010-11).
- Bladder cancer survival is higher in men than women.
- Bladder cancer survival is highest for men diagnosed aged under 50 years old, but highest for women diagnosed age 50-59.
- Three-quarters of men diagnosed aged 15-49 survive their disease for five years or more, compared with 4 in 10 men diagnosed aged 80 and over.
- 6 in 10 women diagnosed aged 50-59 survive their disease for five years or more, compared to less than a third of women diagnosed aged 80 and over.
- Bladder cancer survival trends are difficult to interpret because of changes in classification and coding practices.
- In the 1970s, a third (33%) of people diagnosed with bladder cancer survived their disease beyond ten years, now it's half (50%).
- When diagnosed at its earliest stage, more than 8 in 10 people with bladder cancer will survive their disease for five years or more, compared with around 1 in 10 people when the disease diagnosed at the latest stage.
- 42% (44% in males and 37% in females) of bladder cancer cases each year in the UK are linked to major lifestyle and other risk factors.
- A person’s risk of developing bladder cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- Smoking is the main avoidable risk factor for bladder cancer, linked to an estimated 37% of bladder cancer cases in the UK.
- An estimated 42% of bladder cancers in the UK are linked to lifestyle factors including smoking, certain occupational exposures (6%), and ionising radiation (3%).
- Coffee drinking may relate to higher bladder cancer risk.
- ‘Two-week wait’ referral is the most common route to diagnosis of bladder cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62 day wait’ are not met by any country for urological cancers.
- Around a tenth of bladder cancer patients receive major surgical resection as part of their cancer treatment.
- Almost 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
- Around three-quarters of patients are given the name of their Clinical Nurse Specialist.
The latest statistics available for bladder cancer in the UK are; incidence 2012, mortality 2012 and survival 2010-2011.
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.
Bladder cancer statistics are difficult to interpret because of different and changing classification/coding practices affecting the definition of invasive
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Stage at diagnosis data is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past.
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Bladder cancer is part of the group 'Urological cancer' for cancer waiting times data. Codes vary per country but broadly include: penis, prostate, testis, other and unspecified male genital organs, kidney, renal pelvis, ureter, bladder, other and unspecified urinary organs, secondary cancers of kidney, renal pelvis, bladder and other unspecified urinary organs.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.